VYTRUS BIOTECH EO -01 (V5P) — Net Asset Quality Index
VYTRUS BIOTECH EO -01 (V5P) has a Net Asset Quality Index of 70.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €14.66 Million minus total liabilities of €4.35 Million yields net assets of €10.31 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read VYTRUS BIOTECH EO -01 (V5P) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
VYTRUS BIOTECH EO -01 Net Asset Quality Index Over Time (2021–2025)
This chart shows how VYTRUS BIOTECH EO -01's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 70.3%, representing net assets of €10.31 Million against total assets of €14.66 Million EUR. For live market cap and overall valuation, see VYTRUS BIOTECH EO -01 stock valuation.
Annual Net Asset Quality Index for VYTRUS BIOTECH EO -01 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for VYTRUS BIOTECH EO -01 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See VYTRUS BIOTECH EO -01 (V5P) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.3% | €10.31 Million | €14.66 Million | €4.35 Million | ▲ +4.8 pp |
| 2024 | 65.5% | €7.29 Million | €11.13 Million | €3.84 Million | ▲ +8.7 pp |
| 2023 | 56.8% | €5.29 Million | €9.31 Million | €4.02 Million | ▼ -2.6 pp |
| 2022 | 59.4% | €4.75 Million | €8.00 Million | €3.25 Million | ▲ +0.2 pp |
| 2021 | 59.2% | €4.25 Million | €7.18 Million | €2.93 Million | — |